IHF GmbH - Institut für Herzinfarktforschung   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Ludwigshafen Germany

Organization Overview

First Clinical Trial
2016
NCT02723981
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

IHF GmbH - Institut für Herzinfarktforschung

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 4)

Angina, Stable (Phase 4)

Angina, Unstable (Phase 4)

Coronary Artery Disease (Phase 3)

Coronary Disease (Phase 4)

Diabetes Mellitus (Phase 3)

Myocardial Infarction (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5